Health Canada Approves CT-P13 SC for RA; Plus Tofacitinib May Increase Cardiac & Cancer Risks
Study Explores Palindromic Rheumatism to Predict RA Development
Modern Treatment Tied to Low Disease Activity in Pregnant RA Patients
Research Outlines Benefits of bDMARDs to Treat Early RA
A High HAQ at Baseline in Early RA Is a Bad Sign
A Closer Look at Antibodies in RA: How Anti-Citrullinated Protein Antibodies, Anti-Modified Protein Autoantibodies & Rheumatoid Factor Activity Overlap
Long-Term Safety of Baricitinib for RA
Upadacitinib Safety Similar to Other Jakinibs for RA
1 Step Closer: Study Examines Factors That Lead to RA in Hope of Developing Prevention Strategies
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 27
- Next Page »